rs7756516

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001300790.2(HLA-DQB2):​c.*313G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.514 in 421,676 control chromosomes in the GnomAD database, including 58,260 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.50 ( 19803 hom., cov: 32)
Exomes 𝑓: 0.52 ( 38457 hom. )

Consequence

HLA-DQB2
NM_001300790.2 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.913

Publications

53 publications found
Variant links:
Genes affected
HLA-DQB2 (HGNC:4945): (major histocompatibility complex, class II, DQ beta 2) HLA-DQB2 belongs to the family of HLA class II beta chain paralogs. Class II molecules are heterodimers consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. They play a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). Polymorphisms in the alpha and beta chains specify the peptide binding specificity, and typing for these polymorphisms is routinely done for bone marrow transplantation. However this gene, HLA-DQB2, is not routinely typed, as it is not thought to have an effect on transplantation. There is conflicting evidence in the literature and public sequence databases for the protein-coding capacity of HLA-DQB2. Because there is evidence of transcription and an intact ORF, HLA-DQB2 is represented in Entrez Gene and in RefSeq as a protein-coding locus. [provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.789 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HLA-DQB2NM_001300790.2 linkc.*313G>A 3_prime_UTR_variant Exon 6 of 6 ENST00000437316.7 NP_001287719.1 Q5SR05
HLA-DQB2NM_001198858.2 linkc.*313G>A 3_prime_UTR_variant Exon 5 of 5 NP_001185787.1 P05538-2
HLA-DQB2XM_011514560.3 linkc.*313G>A 3_prime_UTR_variant Exon 5 of 5 XP_011512862.1
HLA-DQB2XM_011514561.4 linkc.*313G>A 3_prime_UTR_variant Exon 4 of 4 XP_011512863.1 A0A2H4Z4R5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HLA-DQB2ENST00000437316.7 linkc.*313G>A 3_prime_UTR_variant Exon 6 of 6 6 NM_001300790.2 ENSP00000396330.2 Q5SR05
HLA-DQB2ENST00000435145.6 linkc.*1094G>A 3_prime_UTR_variant Exon 5 of 5 6 ENSP00000410512.2 A2ADX3
HLA-DQB2ENST00000411527.5 linkc.*313G>A 3_prime_UTR_variant Exon 5 of 5 6 ENSP00000390431.1 P05538-2
HLA-DQB2ENST00000427449.1 linkc.*313G>A downstream_gene_variant 6 ENSP00000415997.1 H0Y7Y7

Frequencies

GnomAD3 genomes
AF:
0.499
AC:
75753
AN:
151908
Hom.:
19773
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.389
Gnomad AMI
AF:
0.686
Gnomad AMR
AF:
0.553
Gnomad ASJ
AF:
0.558
Gnomad EAS
AF:
0.810
Gnomad SAS
AF:
0.683
Gnomad FIN
AF:
0.577
Gnomad MID
AF:
0.630
Gnomad NFE
AF:
0.497
Gnomad OTH
AF:
0.522
GnomAD4 exome
AF:
0.522
AC:
140818
AN:
269648
Hom.:
38457
Cov.:
0
AF XY:
0.527
AC XY:
72900
AN XY:
138254
show subpopulations
African (AFR)
AF:
0.383
AC:
3568
AN:
9318
American (AMR)
AF:
0.580
AC:
6020
AN:
10380
Ashkenazi Jewish (ASJ)
AF:
0.555
AC:
5289
AN:
9536
East Asian (EAS)
AF:
0.723
AC:
16339
AN:
22590
South Asian (SAS)
AF:
0.601
AC:
7168
AN:
11928
European-Finnish (FIN)
AF:
0.548
AC:
9817
AN:
17906
Middle Eastern (MID)
AF:
0.637
AC:
846
AN:
1328
European-Non Finnish (NFE)
AF:
0.490
AC:
83078
AN:
169564
Other (OTH)
AF:
0.508
AC:
8693
AN:
17098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
2845
5690
8536
11381
14226
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.499
AC:
75843
AN:
152028
Hom.:
19803
Cov.:
32
AF XY:
0.509
AC XY:
37827
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.390
AC:
16145
AN:
41436
American (AMR)
AF:
0.553
AC:
8459
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.558
AC:
1936
AN:
3470
East Asian (EAS)
AF:
0.810
AC:
4199
AN:
5186
South Asian (SAS)
AF:
0.682
AC:
3285
AN:
4814
European-Finnish (FIN)
AF:
0.577
AC:
6098
AN:
10562
Middle Eastern (MID)
AF:
0.643
AC:
189
AN:
294
European-Non Finnish (NFE)
AF:
0.497
AC:
33791
AN:
67960
Other (OTH)
AF:
0.529
AC:
1118
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1875
3750
5626
7501
9376
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
688
1376
2064
2752
3440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.490
Hom.:
54572
Bravo
AF:
0.491
Asia WGS
AF:
0.705
AC:
2446
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
8.2
DANN
Benign
0.75
PhyloP100
0.91
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7756516; hg19: chr6-32723917; API